Breakdown | |||||
TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
25.69B | 27.37B | 20.91B | 20.35B | 20.90B | 21.21B | Gross Profit |
26.61B | 0.00 | 20.91B | 20.35B | 20.90B | 21.21B | EBIT |
3.69B | 699.00M | -4.30B | 1.33B | 2.58B | 2.25B | EBITDA |
-4.05B | 699.00M | -3.37B | 2.57B | 4.69B | 4.60B | Net Income Common Stockholders |
-2.38B | 1.86B | -3.30B | 1.47B | 2.58B | 2.16B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
230.62B | 0.00 | 165.70B | 248.75B | 186.75B | 216.19B | Total Assets |
1.83T | 1.81T | 1.76T | 1.89T | 1.81T | 1.80T | Total Debt |
120.22B | 118.03B | 119.03B | 126.69B | 151.45B | 111.45B | Net Debt |
-110.40B | 118.03B | -46.67B | -122.06B | -35.29B | -104.73B | Total Liabilities |
1.75T | 1.73T | 1.68T | 176.92B | 1.73T | 1.71T | Stockholders Equity |
75.53B | 71.65B | 78.40B | 73.67B | 81.13B | 85.68B |
Cash Flow | Free Cash Flow | ||||
0.00 | 29.22B | -144.48B | 57.40B | -1.07B | 140.68B | Operating Cash Flow |
0.00 | 30.27B | -143.30B | 58.32B | 77.00M | 141.15B | Investing Cash Flow |
0.00 | -3.74B | 61.00B | 4.83B | -28.35B | -20.73B | Financing Cash Flow |
0.00 | 50.94B | -695.00M | -797.00M | -719.00M | -661.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
72 Outperform | ¥99.90B | 6.79 | 4.58% | -12.29% | 108.55% | ||
71 Outperform | $174.21B | 9.43 | 3.81% | 3.49% | 7.03% | 8.58% | |
70 Outperform | $748.74B | 10.22 | 7.30% | 3.59% | 15.35% | -1.62% | |
65 Neutral | $569.29B | 11.57 | 4.55% | 4.95% | 16.68% | 1.73% | |
64 Neutral | $6.52B | 10.80 | 6.50% | 5.16% | 24.88% | -1.54% | |
42 Neutral | ¥15.93B | 8.42 | 4.36% | -8.20% | -939.22% |